BMY Bristol-Myers Squibb
Stock · NYSE · United States · Healthcare · US1101221083
NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by Bristol-Myers Squibb, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price
62.67 USD
-0.74%
52-week range
45.27 – 68.64
Dividend yield3.99%
Market cap129.0B
NowoTrade score
70 Grade A
Price history
Daily prices in USD.
Updated 06 Nov 2026 17:29. Information, not advice.
Results
Next results
04 Feb 2027
in 90 days · 08:00 · estimate 1.50
Last results
1.35 vs 1.17 estimated
29 Oct 2026 · Beat +15.2%
Beat the estimate
11 of 12
0 missed · 1 in line · 10 beats in a row
Average surprise
+15.6%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 04 Feb 2027 08:00 | 1.50 | — | — | Upcoming |
| 29 Oct 2026 07:00 | 1.17 | 1.35 | +15.2% | Beat |
| 30 Jul 2026 07:00 | 1.60 | 2.04 | +27.7% | Beat |
| 30 Apr 2026 07:00 | 1.42 | 1.58 | +11.2% | Beat |
| 05 Feb 2026 07:00 | 1.20 | 1.26 | +4.6% | Beat |
| 30 Oct 2025 07:00 | 1.52 | 1.63 | +7.6% | Beat |
| 31 Jul 2025 07:00 | 1.10 | 1.46 | +32.6% | Beat |
| 24 Apr 2025 07:00 | 1.50 | 1.80 | +19.9% | Beat |
| 06 Feb 2025 06:00 | 1.47 | 1.67 | +13.8% | Beat |
| 31 Oct 2024 06:00 | 1.50 | 1.80 | +20.0% | Beat |
| 26 Jul 2024 06:00 | 1.63 | 2.07 | +27.4% | Beat |
| 25 Apr 2024 06:00 | -4.40 | -4.40 | -0.1% | In line |
| 02 Feb 2024 06:00 | 1.58 | 1.70 | +7.8% | Beat |
| 26 Oct 2023 06:00 | 1.77 | 2.00 | +13.0% | Beat |
| 27 Jul 2023 07:00 | 1.99 | 1.75 | -12.0% | Miss |
| 27 Apr 2023 06:00 | 1.97 | 2.05 | +3.9% | Beat |
| 02 Feb 2023 06:00 | 1.73 | 1.82 | +5.2% | Beat |
| 25 Oct 2022 19:00 | 1.83 | 1.99 | +8.5% | Beat |
| 27 Jul 2022 06:00 | 1.80 | 1.93 | +7.3% | Beat |
| 29 Apr 2022 06:00 | 1.90 | 1.96 | +3.3% | Beat |
| 04 Feb 2022 06:00 | 1.80 | 1.83 | +1.7% | Beat |
| 27 Oct 2021 06:00 | 1.92 | 2.00 | +4.3% | Beat |
| 28 Jul 2021 06:00 | 1.90 | 1.93 | +1.8% | Beat |
| 29 Apr 2021 06:00 | 1.81 | 1.74 | -3.9% | Miss |
| 04 Feb 2021 06:00 | 1.42 | 1.46 | +3.1% | Beat |
Annual results
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 48.2B | -0.2% | 7.1B | 14.6% | 3.46 | +178.5% | 12.8B |
| 2024 | 48.3B | +7.3% | -8.9B | -18.5% | -4.41 | -214.2% | 13.9B |
| 2023 | 45B | -2.5% | 8B | 17.8% | 3.86 | +30.8% | 12.7B |
| 2022 | 46.2B | — | 6.3B | 13.7% | 2.95 | — | 11.9B |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 06 Apr 2023 | 69.69 | 71.07 | 69.60 | 70.74 | +1.32% | 9,669,500 | 0.5700 |
| 05 Apr 2023 | 69.46 | 70.21 | 69.04 | 69.82 | +1.32% | 7,739,000 | |
| 04 Apr 2023 | 69.78 | 69.78 | 68.63 | 68.91 | -1.12% | 8,626,700 | |
| 03 Apr 2023 | 69.03 | 70.01 | 68.67 | 69.69 | +0.55% | 7,333,900 | |
| 31 Mar 2023 | 68.66 | 69.38 | 68.37 | 69.31 | +1.63% | 8,953,200 | |
| 30 Mar 2023 | 68.38 | 68.53 | 67.99 | 68.20 | +0.03% | 4,400,100 | |
| 29 Mar 2023 | 68.22 | 68.46 | 67.86 | 68.18 | -0.03% | 5,369,900 | |
| 28 Mar 2023 | 68.08 | 68.59 | 67.96 | 68.20 | +0.19% | 4,715,100 | |
| 27 Mar 2023 | 68.09 | 68.82 | 68.01 | 68.07 | +0.58% | 6,711,300 | |
| 24 Mar 2023 | 67.20 | 67.78 | 66.69 | 67.68 | +1.05% | 6,274,900 | |
| 23 Mar 2023 | 67.59 | 67.90 | 66.64 | 66.98 | -0.39% | 6,723,600 | |
| 22 Mar 2023 | 67.49 | 68.00 | 67.22 | 67.24 | -0.40% | 6,657,600 | |
| 21 Mar 2023 | 67.48 | 67.81 | 66.87 | 67.51 | +0.40% | 8,039,600 | |
| 20 Mar 2023 | 66.73 | 67.38 | 66.24 | 67.24 | +1.07% | 9,731,700 | |
| 17 Mar 2023 | 67.33 | 67.33 | 66.21 | 66.53 | -0.85% | 21,616,900 | |
| 16 Mar 2023 | 67.03 | 67.61 | 65.86 | 67.10 | -0.56% | 10,541,100 | |
| 15 Mar 2023 | 66.12 | 67.72 | 66.06 | 67.48 | +1.52% | 10,701,900 | |
| 14 Mar 2023 | 66.30 | 66.56 | 65.76 | 66.47 | +0.71% | 9,408,400 | |
| 13 Mar 2023 | 65.41 | 67.09 | 65.28 | 66.00 | +0.44% | 9,598,000 | |
| 10 Mar 2023 | 66.32 | 67.41 | 65.43 | 65.71 | -1.20% | 10,282,400 | |
| 09 Mar 2023 | 67.60 | 67.72 | 66.33 | 66.51 | -1.16% | 7,553,600 | |
| 08 Mar 2023 | 67.91 | 68.05 | 66.94 | 67.29 | -1.04% | 5,962,900 | |
| 07 Mar 2023 | 69.18 | 69.21 | 67.44 | 68.00 | -1.31% | 8,135,800 | |
| 06 Mar 2023 | 69.37 | 69.66 | 68.73 | 68.90 | -0.58% | 7,000,100 | |
| 03 Mar 2023 | 69.36 | 69.42 | 68.81 | 69.30 | +0.16% | 6,540,100 |
Page 37 of 51
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
Key data
- Previous close
- 63.13 USD
- Market cap
- 129.0B
- Dividend yield
- 3.99%
- 5-year average yield
- 3.86%
- Payout ratio
- 56%
- Last dividend
- 0.6300 USD · 02 Oct 2026
- Exchange
- NYSE
- Country
- United States
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Currency
- USD
Dividends
| Ex-dividend date | Per share |
|---|---|
| 02 Oct 2026 | 0.6300 USD |
| 02 Jul 2026 | 0.6300 USD |
| 02 Apr 2026 | 0.6300 USD |
| 02 Jan 2026 | 0.6300 USD |
| 03 Oct 2025 | 0.6200 USD |
| 03 Jul 2025 | 0.6200 USD |
| 04 Apr 2025 | 0.6200 USD |
| 03 Jan 2025 | 0.6200 USD |
| 04 Oct 2024 | 0.6000 USD |
| 05 Jul 2024 | 0.6000 USD |
| 04 Apr 2024 | 0.6000 USD |
| 04 Jan 2024 | 0.6000 USD |
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Yield Dividends per year as a share of today's price. Very high yields count for less: they often signal trouble. | 16.6 / 25 |
|
| Dividend safety Can the company keep paying? The dividend against free cash flow and earnings, plus debt and interest cover. | 23.1 / 25 |
|
| Dividend growth How many years in a row the dividend has risen, and how fast. | 7.4 / 15 |
|
| Quality Return on equity, net margin and how stable the margins are. | 10.0 / 15 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 9.1 / 10 |
|
| Analysts How far the analysts' average target is from today's price. | 2.3 / 5 |
|
Income profile: it pays a dividend, so it is scored mainly on the dividend and how safe it is. Based on 95% of the figures (grade A).
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio.
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (trailing) | 14.07× | Good | 32.71× |
| P/E (forward) | 9.54× | Good | 15.76× |
| Price / book | 5.54× | Weak | 3.74× |
| Price / sales | 2.59× | Fair | 3.52× |
| EV / EBITDA | 8.96× | Good | 13.54× |
| Free cash flow yield | 4.9% | Fair | 3% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 70.5% | Good | 66.1% |
| Operating margin | 33.8% | Good | 8% |
| Net margin | 18.5% | Good | 3.5% |
| Return on equity | 44% | Good | 6.4% |
| Return on assets | 10.9% | Good | 3.9% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | 1.4% | Weak | 10.5% |
| EPS growth / year | 5.5% | Fair | 7% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 1.91× | Weak | 0.52× |
| Net debt / EBITDA | 1.77× | Fair | 1.62× |
| Interest cover | 7.26× | Fair | 3.3× |
| Current ratio | 1.59× | Good | 2.12× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 55.9% | Fair | 0% |
| Payout of free cash flow | 79.3% | Weak | 45% |
| Payout of free cash flow (3 years) | 37.2% | Good | — |
| Dividend growth / year | 4.7% | Fair | 7.1% |
| Years of rising dividends | 4 | Fair | 4.5 |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Follow BMY and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.